Elafin for gluten toxicity faces GMO hurdle, researchers say


Food Navigator

A protein that could help fight celiac disease gut symptoms may struggle to overcome strict EU rules on genetically modified organisms, says Philippe Langella, the research director of the institute behind the project.

Researchers from the French National Institute for Agricultural Research (INRA) and the French National Institute of Health and Medical Research (INSERM) have developed a strategy to deliver the human protein elafin - a protease inhibitor - into the guts of mice to reduce inflammatory symptoms associated with celiac disease.

The full article is available here.


Latest News